CJC-1295 no DAC 5mg + IPA 5mg
10mg
❄️Lyophilized powder (not reconstituted)
Discount per Quantity
| Quantity | Discount | Price per Unit |
|---|---|---|
| 5 - 10 | 10% | €58.49 |
| 11 - 20 | 15% | €55.24 |
| 21+ | 20% | €51.99 |
Rigorous third-party testing
Every batch of our research chemicals and peptides undergoes independent third-party laboratory testing for purity and identity.
Total: €64.99
CJC-1295 no DAC 5 mg + Ipamorelin 5 mg is supplied as a catalogued research material in 10 mg total nominal catalogue presentation: 5 mg + 5 mg.
This product is a mixture and has no single formula, mass or registry identifier. The exact CJC no-DAC species, both component salt forms and the catalogue-stated 5 mg + 5 mg ratio require confirmation in the matching CoA [1–4].
Chemical properties and registry information
| Property | Value |
|---|---|
| Name and synonyms | Mod GRF (1-29) / Ipamorelin Blend, CJC-1295 without DAC and Ipamorelin |
| Material category | GHRH / GHRP Peptide Blend |
| Structural features | A blend of two peptides: Modified GRF (1-29), a GHRH analogue, and Ipamorelin, a GHRP. |
| Appearance | White to off-white lyophilised powder |
| Solubility | Reconstitute with bacteriostatic water. Both peptides in the blend are water-soluble. |
| Physical form | Catalogue vial; exact salt/counter-ion and excipients are batch-specific and must be verified in the CoA and SDS. |
Registry values apply only to the specific molecular entity, sequence, termini and material form. Batch records take precedence over family-level literature identifiers.
This product is a physical mixture of two distinct peptides: CJC-1295 without DAC (also known as Mod GRF 1-29) and Ipamorelin. As a blend, it does not have a single chemical formula, molecular weight, or registry number. The components are typically co-lyophilized.
Research background and published evidence
Published research
Modified GRF species and ipamorelin have been studied separately in receptor, signaling, analytical and investigational pharmacology research; this does not create evidence for the combined mixture [1–4].
Current scientific understanding
No controlled blend-specific human evidence was identified. Human CJC-1295 studies commonly concern the DAC conjugate, while ipamorelin studies concern separately manufactured material; neither can be transferred to this blend.
“10 mg total” is a nominal two-component catalogue presentation, not the molecular mass of one substance or a dose.
Technical comparison
| Aspect | This catalogue material | Comparator |
|---|---|---|
| Identity | Physical CJC no-DAC and ipamorelin mixture with component forms requiring confirmation | Separately defined and independently assayed CJC no-DAC and ipamorelin reference materials |
| Structural distinction | Two analytes in one presentation; CJC species and both salts remain batch-specific | Each reference has one exact sequence, terminal state, salt form and expected mass |
| Analytical implication | Identify and quantify each component independently and verify the component ratio | Separate standards permit component-specific mass, retention and sequence confirmation |
Quality and testing
Quality information is batch- and presentation-specific. Use only the report linked to the exact size and lot. A report listed for another size, lot or similarly named material must not be treated as evidence for this product.
Chromatographic area purity, identity, net peptide or analyte content, water or counter-ion content, sterility, endotoxin and elemental impurities are different measurements. One result does not establish the others. Only tests supported by a visible, matching report should be regarded as available.
Laboratory handling and storage
Store and handle only under the conditions stated on the product label, batch CoA and SDS. Keep the container secured, correctly identified and protected from contamination. Do not infer storage, solvent compatibility or stability from a related compound.
Laboratory preparation, analytical-method selection, risk assessment, personal protective equipment and waste disposal should follow the applicable SDS and the institution's approved procedures.
Regulatory and legal status
| Research-use notice | This material is supplied exclusively for laboratory research by qualified professionals and is not intended for human or veterinary use. Purchasers are responsible for compliance with applicable local requirements. |
Sources and references
- [1] U.S. FDA. Identity review of CJC-1295-related substances and DAC/no-DAC distinctions.
- [2] Timms et al. LC–MS characterization of CJC-1295-related peptide species (2019).
- [3] PubChem. Ipamorelin, CID 9831659.
- [4] U.S. FDA. Identity, safety and evidence review of ipamorelin.
Frequently Asked Questions
Do the CAS number and PubChem CID apply to every batch form?
Only when the exact sequence or structure, termini, conjugation, salt or counter-ion and hydration state match. The batch CoA and SDS govern; a related-compound identifier must not be substituted.
What does an analytical purity result mean?
It is method- and report-specific. For example, an HPLC area percentage is not automatically the same as identity, net content, sterility, endotoxin status or absence of elemental impurities.
How should the material be stored and handled?
Follow the exact label, batch CoA and SDS together with the institution's risk assessment. Use only storage and stability information linked to the exact material form and batch.